-
公开(公告)号:US10597705B2
公开(公告)日:2020-03-24
申请号:US16154529
申请日:2018-10-08
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
IPC: C12Q1/68 , C12Q1/6853 , C12Q1/6844 , C12Q1/6806 , C12P19/34 , C12Q1/6869 , C12Q1/6874 , C12Q1/6834 , C12Q1/46
Abstract: In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
-
公开(公告)号:US20160186224A1
公开(公告)日:2016-06-30
申请号:US15071086
申请日:2016-03-15
Applicant: Life Technologies Corporation
Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
IPC: C12P19/34
CPC classification number: C12Q1/46 , C12P19/34 , C12Q1/6834 , C12Q1/6846 , C12Q1/6853 , C12Q1/6869 , C12Q1/6874 , C12Q2531/119 , C12Q2565/537
Abstract: In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
-
公开(公告)号:US10093969B2
公开(公告)日:2018-10-09
申请号:US15695244
申请日:2017-09-05
Applicant: Life Technologies Corporation
Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
IPC: C12Q1/68 , C12Q1/6853 , C12P19/34 , C12Q1/6874 , C12Q1/6869 , C12Q1/6834 , C12Q1/6844 , C12Q1/46
Abstract: In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
-
公开(公告)号:US09315861B2
公开(公告)日:2016-04-19
申请号:US14360892
申请日:2012-11-28
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
CPC classification number: C12Q1/46 , C12P19/34 , C12Q1/6834 , C12Q1/6846 , C12Q1/6853 , C12Q1/6869 , C12Q1/6874 , C12Q2531/119 , C12Q2565/537
Abstract: In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
Abstract translation: 在一些实施方案中,用于连接核酸末端的方法包括:在存在可产生可连接的末端5'磷酸基团的至少一种试剂的存在下进行核酸连接反应,通过从核酸的末端5'磷酸脱除腺苷酸基 。 在一些实施方案中,阿伐他汀酶可以催化从核酸的末端5'磷酸脱除腺苷酸基团。 在一些实施方案中,用于连接核酸末端的方法包括:在适于连接核酸末端的条件下,在阿伐他汀酶存在下进行核酸连接反应。
-
公开(公告)号:US09765388B2
公开(公告)日:2017-09-19
申请号:US15071086
申请日:2016-03-15
Applicant: Life Technologies Corporation
Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
CPC classification number: C12Q1/46 , C12P19/34 , C12Q1/6834 , C12Q1/6846 , C12Q1/6853 , C12Q1/6869 , C12Q1/6874 , C12Q2531/119 , C12Q2565/537
Abstract: In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
-
公开(公告)号:US20150031026A1
公开(公告)日:2015-01-29
申请号:US14360892
申请日:2012-11-28
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
CPC classification number: C12Q1/46 , C12P19/34 , C12Q1/6834 , C12Q1/6846 , C12Q1/6853 , C12Q1/6869 , C12Q1/6874 , C12Q2531/119 , C12Q2565/537
Abstract: In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
Abstract translation: 在一些实施方案中,用于连接核酸末端的方法包括:在存在可产生可连接的末端5'磷酸基团的至少一种试剂的存在下进行核酸连接反应,通过从核酸的末端5'磷酸脱除腺苷酸基 。 在一些实施方案中,阿伐他汀酶可以催化从核酸的末端5'磷酸脱除腺苷酸基团。 在一些实施方案中,用于连接核酸末端的方法包括:在适于连接核酸末端的条件下,在阿伐他汀酶存在下进行核酸连接反应。
-
-
-
-
-